Cargando…
miR-30b-5p Downregulation as a Predictive Biomarker of Coronary In-Stent Restenosis
In-stent restenosis (ISR) is one of the main limitations of percutaneous coronary intervention (PCI) therapy with drug-eluting stents (DES) implantation. The aim of this study was to determine if circulating microRNAs (miRNAs) have diagnostic capability for determining ISR in a cohort of matched pat...
Autores principales: | Gutierrez-Carretero, Encarnación, Mayoral-González, Isabel, Jesús Morón, Francisco, Fernández-Quero, Mónica, Domínguez-Rodríguez, Alejandro, Ordóñez, Antonio, Smani, Tarik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066146/ https://www.ncbi.nlm.nih.gov/pubmed/33808387 http://dx.doi.org/10.3390/biomedicines9040354 |
Ejemplares similares
-
Circulating miR-320a as a Predictive Biomarker for Left Ventricular Remodelling in STEMI Patients Undergoing Primary Percutaneous Coronary Intervention
por: Galeano-Otero, Isabel, et al.
Publicado: (2020) -
Hypersensitivity and in-stent restenosis in coronary stent materials
por: Hu, Wansong, et al.
Publicado: (2022) -
Cardiac protection induced by urocortin-2 enables the regulation of apoptosis and fibrosis after ischemia and reperfusion involving miR-29a modulation
por: Mayoral-González, Isabel, et al.
Publicado: (2022) -
Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011) -
Heavy Coronary Calcium Mimicking In-Stent Restenosis
por: Park, Jeong-Hwan, et al.
Publicado: (2011)